Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 159 participants.
Also called NCT01788150
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 159 participants
- Sponsor
- Svelte Medical Systems, Inc.
- Registry
-
NCT01788150
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Belgium, Czechia, France, Germany, Netherlands, Sweden, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT01788150. Randomized; no masking; primary purpose treatment. Start 2013-01 (actual); primary completion 2014-05 (actual). Results posted on 2021-05-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System
- Acronym
- DIRECT II
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Coronary Stenting
- Lead sponsor
- Svelte Medical Systems, Inc.
Record details
- Record id
cardio:ct-nct01788150- Content hash
edafc011fb8360ab01f1db15d4979a2495bd223c4ab509e25c32bfd1c5ad71ac